STAAR Surgical (NASDAQ:STAA) Price Target Cut to $41.00 by Analysts at Canaccord Genuity Group

STAAR Surgical (NASDAQ:STAA – Free Report) had its price target decreased by Canaccord Genuity Group from $43.00 to $41.00 in a research note released on Thursday morning, Benzinga reports. Canaccord Genuity Group currently has a hold rating on the medical instruments supplier’s stock. A number of other research analysts have also recently issued reports on […]

Leave a Reply

Your email address will not be published.

Previous post Melco Resorts & Entertainment (MLCO) Scheduled to Post Earnings on Tuesday
Next post TRACON Pharmaceuticals (NASDAQ:TCON) Research Coverage Started at StockNews.com